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We have recently reported the X-ray crystal structure of a fragment of the fusion protein (F) of Newcastle disease virus
(NDV). This work describes the methodology involved in the production and crystallization of that protein in recombinant form.
The full-length cDNA of NDV-F was cloned and the ectodomain expressed in both CHO-K1 and Lec-3.2.8.1 cells. The
recombinant protein, secreted as a single-chain polypeptide F0, was purified using a c-myc antibody affinity column followed
by gel filtration chromatography. Electron microscopic imaging showed the F0 product to consist of unaggregated club-
shaped particles. Trypsin treatment of F0 could be used to produce disulfide-linked F2 and F1 chains. However, imaging
revealed extensive rosette-like aggregation of the trypsin-treated material, indicative of a conformational change. Only the
non-trypsin-treated product was thus suitable for crystallization and two crystal forms were obtained, diffracting to ca. 3.5
and 4.0 Å, respectively. Both crystal forms were used in the structure determination.
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INTRODUCTION
Newcastle disease virus (NDV) belongs to the genus
Rubulavirus within the Paramyxoviridae family of nega-
tive-stranded RNA viruses. The fusion glycoprotein (F) is
common to all members of the family and is believed to
mediate the event of membrane fusion (Morrison and
Portner, 1991). F proteins are synthesized as inactive
precursors F0, which are subsequently cleaved by host
cell proteases into a biologically active form composed
of a pair of disulfide-linked polypeptides F2 and F1, with
F2 N-terminal to F1 (Homma and Tamagawa, 1973;
Scheid and Choppin, 1974). The newly generated N-
terminus of F1 contains the so-called fusion peptide, a
hydrophobic region of approximately 25 residues highly
conserved among the Paramyxoviridae family (Scheid
and Choppin, 1977; Gething et al., 1978). The fusion
peptide is believed to play a critical role in the fusion
event via its interaction with membranes (Gething et al.,
1978; Scheid et al., 1978).
Paramyxoviridae F proteins contain two heptad repeat
regions: HR-A (or HR1), immediately C-terminal to the
fusion peptide (Chambers et al., 1990); and HR-B (or
HR2), immediately N-terminal to the transmembrane an-
chor which is located near the C-terminus of F1 (Buck-
land and Wild, 1989). Crystal structures of pairs of pep-
tides encompassing these heptad repeat regions from
both simian parainfluenza virus 5 (Baker et al., 1999) and
human respiratory syncytial virus (Zhao et al., 2000)
show that they assemble into a hexameric structure, with
the HR-A peptides forming a central three-stranded
coiled coil into the grooves of which pack individual
HR-B peptides in an anti-parallel orientation. The hexa-
meric assembly is believed to represent the conforma-
tion of these elements in the postfusion form of the intact
protein (Weissenhorn et al., 1999), with the fusion peptide
and transmembrane anchor then implicitly in close prox-
imity. However, beyond these experiments, little is known
about the tertiary or quaternary structure of the F protein.
This contrasts with the situation regarding influenza virus
hemagglutinin (HA), which has been the subject of ex-
tensive structural investigation, in both its pre- and its
postfusion forms (Skehel and Wiley, 2000). HA exhibits
some structural similarity to the F protein in that it also
consists of two disulfide-linked polypeptide chains de-
rived from a nonfusogenic precursor and the fusion pep-
tide and transmembrane anchor are located in equiva-
lent positions. However, beyond that, significant differ-
ences must exist between HA and F protein given the
almost opposite length ratios of their two constituent
chains and the absence of any apparent primary se-
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quence homology. In addition, the proteins operate in
different environments (extracellular vs endosomal) and
the fusion event is possibly triggered via different mech-
anisms (pH vs a potential interaction with cognate hem-
agglutinin-neuraminidase).
To understand better the mechanism of fusion in
paramyxoviruses, we initiated structural studies of
NDV-F and subsequently determined the structure of the
ectodomain via X-ray crystallography to 3.3 Å resolution
(Chen et al., 2001). We describe here the cDNA cloning,
production, and purification of the protein used in the
X-ray study. In particular, our clones were derived from
an avirulent strain of NDV wherein the F protein lacks the
normal polybasic furin cleavage site between F2 and F1
(Gorman et al., 1988, 1990). Thus it was possible to
produce a single chain recombinant polypeptide (which
we term herein F0, where the prime denotes the absence
of transmembrane and cytoplasmic elements) by expres-
sion in mammalian cell cultures. Electron microscopic
(EM) analysis showed that F0 undergoes a transition to
an aggregated form upon treatment with trypsin. How-
ever, non-trypsin-treated F0 remains unaggregated and
crystals of this protein were obtained in two forms. Our
EM analysis also provided information about the molec-
ular dimensions and shape which proved invaluable in
the X-ray structure determination (Chen et al., 2001).
Details of this analysis are also described here.
RESULTS AND DISCUSSION
Cloning of the cDNA of NDV-F
The cDNA of NDV-F was cloned by RT-PCR from the
negative-stranded viral RNA isolated from purified virus.
The PCR-amplified full-length cDNA of F was cloned into
the pCR-Script cloning vector for sequencing. The full
nucleotide sequence contained the transcriptional start
signal, a noncoding region, the region coding for the
signal peptide and mature F-protein, a stop codon, and a
noncoding region (Gorman et al., 1988; Toyoda et al.,
1989). The nucleotide sequence has been deposited in
GenBank (Accession No. AF217084). The deduced amino
acid sequence of the coding region (Fig. 1) lies between
that of NDV strains D26/76 and that previously described
for the Que/66 strain (Toyoda et al., 1989). It differs from
the D26/76 strain by five residues at positions 19 (Val vs
Ile), 31 (Ala vs Ser), 170 (Asn vs Asp), 261 (Ser vs Gly), and
506 (Val vs Phe), and from the original Que/66 isolate by
six residues at positions 153 (Arg vs Leu), 346–348 (Tyr-
Cys-Thr vs Phe-Phe-Ser), and 426–427 (Ile-Leu vs Met-
Phe). Interestingly, the five residues Val 19, Ala 31,
FIG. 1. The amino acid sequence of the F-gene product deduced from the cloned cDNA from the vaccine preparation of the V4 (Que/66 strain) of
NDV compared to that previously reported for the Que/66 and D26/76 isolates (Toyoda et al., 1989). The N-terminal signal peptide, the fusion peptide,
and the transmembrane region at the C-terminus are boxed. Cysteine residues are shaded, while potential N-linked glycosylation sites are underlined.
The F2/F1 cleavage site is indicated by a vertical double arrow (Gorman et al., 1988, 1992). The recombinant construct encodes residues 1 to 499
followed by the C-terminal sequence SREQKLISEEDLN (see Materials and Methods).
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Asn170, Ser 261, and Val 506 that differ from D26/76 are
conserved in Que/66, and the six residues Arg 153, Tyr
346, Cys 347, Thr 348, Ile 426, and Leu 427 that differ from
Que/66 are conserved in the D26/76 strain. We note that
the reported substitution of Phe for Cys 347 in Que/66
(Toyoda et al., 1989) is possibly a sequencing error, given
that in Sendai virus F protein this residue is in disulfide
linkage (Iwata et al., 1994), and there does not appear to
be a concomitant change of the corresponding partner
residue at Cys 338 in Que/66.
Expression of the ectodomain of NDV-F in
mammalian cells
The DNA fragment Fectodomain-c-myc, which contained the
transcriptional start signal, the sequence coding for the
signal peptide and entire ectodomain of NDV fusion
protein, c-myc tag, and stop codon, was constructed and
cloned into EcoRI site of the mammalian cell expression
vector pEE14. This vector contained the glutamine syn-
thetase gene that allowed for clone selection (Bebbing-
ton and Hentschel, 1987). The c-myc tag EQKLISEEDLN
(Hoogenboom et al., 1991) was incorporated onto the
C-terminus of the ectodomain to facilitate clone identifi-
cation and downstream protein purification (McKern et
al., 1997). The resulting vector pEE14-FNDV was trans-
fected into two mammalian cell lines CHO-K1 and Lec-
3.2.8.1 and stable lines were generated. The CHO-K1 cell
line produces protein with complex carbohydrates which
are sometimes required for correct protein folding and
hence for crystal formation. The Lec-3.2.8.1 cell line pro-
duces protein with simpler and more homogeneous car-
bohydrates which may be advantageous to crystalliza-
tion and may be more representative of F protein pro-
duced during natural infection (Diabate et al., 1984). The
transfection efficiency of the CHO-K1 cell line was found
to be considerably higher than that of the Lec-3.2.8.1 cell
line. The positive clones were identified from the trans-
fectants using dot blot analysis and the cells secreting
the highest levels of F protein were subcloned by limiting
dilution and amplified. The best expressing CHO-K1
clone, AB1(2), and the Lec-3.2.8.1 clone, BG8(5), were
selected for the large-scale production of the protein as
adherent cultures in T-flasks or spinner flasks. In gen-
eral, the CHO-K1 cell line also expressed a higher level
of F protein than the Lec-3.2.8.1 cell line.
Purification and characterization of the
recombinant F0
The c-myc-tagged F-protein ectodomain was isolated
from cell culture supernatants by binding to an anti-c-
myc affinity column. The bound protein was eluted from
the column with the c-myc peptide followed by pH 3.0
buffer. Elution efficiency was increased by recycling the
peptide solution through the column several times before
collection (McKern et al., 1997). The protein recovered
from the affinity column was further purified using a
Superose-6 gel-filtration column. The chromatographic
profile showed a main protein peak at Mr  160K (Fig.
2A). MALDI-MS measurement of the purified F-protein
ectodomain detected a major species of molecular mass
59,780 Da—presumably that of the glycosylated ectodo-
main monomer (data not shown).
N-terminal amino acid sequencing of the protein from
the main peak of the gel-filtration column gave a single
sequence with the first 10 residues being LDGRPLAAAG,
indicating the successful processing of the signal pep-
tide leading to the authentic N-terminus of the mature
protein precursor (Gorman et al., 1988). The CHO-K1 cell
expressed protein migrated as a band of Mr  60K on
SDS–PAGE gel (Fig. 2B), consistent with the MALDI-MS
measurement of the protein. The Lec-3.2.8.1 cell ex-
pressed protein migrated at a lower molecular weight,
presumably due to the expected smaller carbohydrate
chains (Fig. 2B). Appearance of the protein as a single
band with similar molecular weight under both reducing
and nonreducing conditions indicated that the F protein
was secreted from both CHO-K1 and Lec-3.2.8.1 cells as
the expected single-chain polypeptide F0, consistent
with the N-terminal sequencing result and earlier reports
that cleavage activation of fusion protein into disulfide-
linked two polypeptides F2 and F1 in tissue culture de-
pends upon the addition of exogenous protease (Nagai
and Klenk, 1977; Gorman et al., 1992).
To investigate in vitro cleavage of the secreted F0 into
disulfide-linked F2 and F1, isolated CHO-K1 cell ex-
pressed F0 was incubated with trypsin and analyzed by
SDS–PAGE (Fig. 2C). Under reducing conditions, a band
with a molecular weight corresponding to the F1 polypep-
tide was observed. Under nonreducing conditions, the
trypsin-treated F0 migrated as a band with the same
molecular weight as that of the untreated protein, indi-
cating that it remained intact as the disulfide-linked F2
and F1. Taken together, these results imply that trypsin
cleaved the F0 at or near the native cleavage site; how-
ever, further though limited fragmentation cannot be ex-
cluded. The F2 polypeptide presumably comigrated with
the bromphenol dye-front. Minor low molecular weight
bands were also apparent in gel—these are presumably
either purification contaminants, minor products of the
trypsin digestion, or minor degradation products intro-
duced by boiling the sample to disassociate the mole-
cule into monomers. Given the limited resolution of the
gel, the proteolytic loss of a few residues from the termini
of the F2 and F1 products can also not be excluded. The
trypsin-treated F0 was also analyzed by Superose-6 gel-
filtration chromatography. The major peak appeared in
the void volume (Fig. 2D) and was found to have an Mr of
60K by SDS–PAGE under nonreducing conditions (data
not shown), implying that the treated protein had aggre-
gated. This aggregation may have been caused by the
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exposure of the hydrophobic fusion peptide, possibly
followed by a conformational change (Hsu et al., 1981).
Electron microscopy of NDV-F
Recombinant F0 produced in CHO-K1 and Lec-3.2.8.1
cells was imaged by negative stain electron microscopy
and the images subjected to single-particle averaging.
Protein was also recovered from the crystals of the
CHO-K1 recombinant material and imaged to ascertain
the nature of the particles contained in the crystal. In all
instances the particles exhibited a club-like appearance
and were predominantly unaggregated (Figs. 3A and 3B),
similar to that observed for virus-derived measles F pro-
tein (Varsanyi et al., 1984). The crystal-derived material
(see below) also showed the characteristic club shape
and was predominantly unaggregated (Fig. 3C). Analysis
of the single-particle averaged images confirmed the
overall similar appearance of the particles obtained from
the CHO-K1 and Lec 3.8.2.1 cell lines (Figs. 3D and 3E);
however, the material derived from the crystals (Fig. 3F)
appeared about 15–20 Å longer than its precrystalline
form.
Trypsin-treated F0 formed rosettes (Fig. 3G). These
rosettes contained on average six to eight particles;
however, larger rosettes containing at least 12 particles
were observed in some micrographs. The rosettes are of
similar appearance to those seen for full-length influenza
virus neuraminidase and hemagglutinin (Laver and Val-
entine, 1969) and for measles virus hemagglutinin
(Varsanyi et al., 1984), where aggregation is due to the
presence of the hydrophobic transmembrane regions.
The observed aggregation is consistent with the in-
crease in hydrophobicity observed for Sendai virus F
protein upon cleavage (Hsu et al., 1981). We propose that
the rosette-like aggregation observed here is most likely
due to the exposure of the hydrophobic fusion peptide
upon proteolysis. It has been demonstrated that the
F-protein fusion peptide is sufficiently hydrophobic to act
FIG. 2. Purification of recombinant F0. (A) Gel-filtration chromatography profile of CHO-K1 cell expressed and affinity-purified recombinant F0. Gel
filtration was conducted on a 24-ml Superose-6 FPLC column with 0.5-ml fractions collected (see text for details). The peak containing F0 is labeled.
(B) SDS–PAGE analysis of F0 expressed in the CHO-K1 and Lec-3.2.8.1 cell lines. The sample was boiled prior to running on the gel. (C) SDS–PAGE
analysis of trypsin-treated F0 obtained from the CHO-K1 cell line (T: trypsin-treated; T  R: trypsin-treated then reduced; NR: no reduction; T  NR:
trypsin-treated without subsequent reduction). The sample was boiled prior to running on the gel. (D) Gel filtration profile obtained as in (A) but
performed after tryptic treatment of the material. The peak containing aggregated F0 is labeled; the position of the minor peak is consistent with that
of buffer salts and other low molecular weight material.
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as a transmembrane anchor (Paterson and Lamb, 1987).
Furthermore, incubation at the pH of fusion of the mem-
brane-anchorless soluble influenza virus HA triggers the
exposure of the fusion peptide and also causes the
molecule to aggregate into rosettes (Skehel et al., 1982;
Doms et al., 1985). However again we cannot rule out the
possibility that additional hydrophobic surfaces are ex-
posed by digestion and that these contribute to the
observed aggregation. The rosettes shown in Fig. 3G are
somewhat similar in appearance to those we obtained
for F protein isolated directly from virus by trypsin treat-
ment of detergent-extracted membrane proteins and
subsequent gel filtration chromatography (data not
shown).
Our results can also be compared directly with the
images obtained for human RSV-F (Calder et al., 2000). In
that work, the authors imaged preparations of both full-
length and membrane-anchorless RSV-F and showed
that both these preparations yielded images with two
characteristic morphologies—a cone-shaped form and a
lollipop-shaped form. The full-length preparations always
appeared in a rosette-like aggregate, similar to that seen
here for trypsin-treated F0. Their membrane-anchorless
preparations appeared as either unaggregated cone-
shaped particles or as aggregated lollipop-shaped par-
ticles. Again, aggregation was always via the stalk. The
overall dimensions of their particles are similar to those
reported here for NDV-F, but we do not discern two
distinct head structures. However, thinning of the stalk is
apparent in some of the aggregates of trypsin-treated
recombinant F0 (Fig. 3G) and in our averaged image of
crystallized material (Fig. 3F). Our interpretation (see
above) of the rosette-like aggregation of trypsin-treated
F0 concurs with that proposed for RSV-F, i.e., aggregation
of membrane-anchorless particles occurs as a result of
exposure of the fusion peptide.
FIG. 3. Electron microscopic imaging and image processing of recombinant F0. (A) CHO-K1 cell expressed F0 particles stained with uranyl formate.
(B) Lec 3.8.2.1 cell expressed F0 particles stained with uranyl acetate. (C) CHO-K1 cell expressed F0 particles from a dissolved crystal, stained with
uranyl formate. (D) Averaged image of CHO-K1 cell expressed F0 particles, derived from a classification and alignment of 349 subimages as described
in the text (subcluster size: 93). The particle is club-shaped with a length of 170 Å. The maximum head width is 75 Å and the maximum tail width
is45 Å. (E) Averaged image of Lec 3.8.2.1 cell expressed F0 particles, derived from a classification and alignment of 363 subimages (subcluster size:
78). The average particle length is 165 Å; the maximum width of the head is 70 Å and of the tail is 45 Å. (F) Averaged image of the CHO-K1
material recovered from a dissolved crystal, derived from a classification and alignment of 566 subimages (subcluster size: 120). The average particle
length is 185 Å; the maximum width of the head is 70 Å and of the tail is 30 Å. (G) CHO-K1 cell expressed F0 particles after trypsin treatment,
stained with uranyl formate, showing rosette formation of club-shaped particles. The length of the scale bar on the micrographs is 500 Å, while on
the averaged images it is 100 Å.
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Crystallization
Uncleaved F0 was judged to be a better candidate for
crystallization trials than the trypsin-treated form, given
the extensive aggregated nature of the latter. Initial
Hampton screens produced needle- or plate-like micro-
crystals from various organic solvents for both the
CHO-K1 and the Lec-3.2.8.1 cell expressed material.
These trials also resulted in one large crystal (ca. 0.5 
0.4  0.2 mm) from 15% PEG 4000 for the CHO-K1 cell
expressed F0, but this crystal diffracted to only 6 Å.
Further tuning of conditions failed to produce any further
useful crystals. Final diffraction-quality crystals were ob-
tained from extensive screening with (NH4)2SO4 or
Li2SO4 as precipitant. Typically, with (NH4)2SO4 as pre-
cipitant, crystals with average size of 0.4 0.3 0.2 mm
were grown from 2 l drops containing 10 mg/ml protein,
10% saturated (NH4)2SO4, and 100 mM MES (pH 6.5) or
Tris (pH 8.5) buffer, equilibrated against a final 0.75–1.0
ml of 35% saturated (NH4)2SO4. These crystals were
somewhat opaque and exhibited a morphology similar to
that of a “bar of soap,” with the complete absence of
facets. With Li2SO4 as precipitant, crystals with an aver-
age size of 0.7 0.25 0.15 mm were grown from drops,
consisting of 1 l protein of 20 mg/ml mixed with 1 l
0.85 M Li2SO4 in 100 mM buffer pH 6.0–7.0 (pH 6.0–6.5,
MES; pH 7.0, HEPES), equilibrated against a final 1.5 ml
1.3 M Li2SO4 in 75 mM buffer pH 6.0–7.0. These crystals
appeared better formed than those grown from ammo-
nium sulfate and exhibited a morphology similar to that
of the “blade of a spear,” sometimes truncated at either
end of the long axis. No crystals suitable for the X-ray
analysis were obtained with the Lec-3.2.8.1 cell ex-
pressed F0, despite the anticipation that material derived
from this cell line may exhibit lower microheterogeneity
than that derived from CHO-K1 cells (Diabate et al.,
1984). We are unable to comment on whether the crys-
tallization of the protein in this form was dependent on a
particular property of the vaccine isolate employed.
Preliminary X-ray analysis
Crystals grown via (NH4)2SO4 precipitation diffracted
to at least 3.5 Å resolution when mounted in an X-ray
capillary at room temperature on the laboratory X-ray
generator. Cryoprotection of the crystals proved prob-
lematic, best results being obtained by adding 40% su-
crose using the stepwise procedure outlined under Ma-
terials and Methods. Under these conditions, it proved
possible to preserve resolution to 3.8 Å. However,
there was a concomitant increase in mosaic spread and
a marked drop in the diffraction intensity at around 4.0 Å.
Analysis of the diffraction images showed the crystals
belonged to the space group C2221 with a  134.39 Å,
b  308.33 Å, and c  243.00 Å; these crystals were
termed the C form. Crystals grown via Li2SO4 precipita-
tion diffracted to at most 4.5 Å resolution at room tem-
perature. Analysis of the diffraction images showed the
crystals belonged to the space group P2221 with a 
68.44 Å, b  152.36 Å, and c  240.89 Å; these crystals
were termed the P form. The cell dimension and space
group of the P-form crystals were clearly related to those
of the C form and indeed it proved possible to generate
P-form crystals via transfer of C-form crystals to Li2SO4 at
the appropriate concentration. Again, adequate cryopro-
tection of P-form crystals was only achieved via use of a
solution containing 40% sucrose. Under these condi-
tions, the preservation of resolution was anisotropic,
varying from 4.5 to 6.0 Å across reciprocal space. The
interrelationship of space groups and cell dimensions of
the C- and P-form crystals implies that the volume of the
C-form asymmetric unit is twice that of the P-form crys-
tals. On the assumption that F0 forms a threefold sym-
metric trimer, then the asymmetric unit of the P-form
crystal most likely contains one such trimer and that of
the C-form two such trimers, yielding a Matthews coef-
ficient of 3.4 Å3/Da and a crystal solvent content of 64%
in both cases.
In summary, we have been able to produce and crys-
tallize recombinant NDV F-protein ectodomain as a sin-
gle-chain form F0. The lack of aggregation of this protein
as demonstrated by EM is most probably a consequence
of producing F0 from a strain of the virus that was unlikely
to undergo cleavage during expression in mammalian
cells. Lack of aggregation undoubtedly aided crystalliza-
tion. Tryptic treatment of the recombinant protein re-
sulted in aggregation as evidenced in EM analysis, con-
sistent with the protein having undergone a conforma-
tional change; these aggregates were similar in
appearance to those observed for virus-derived NDV-F
(data not shown). The EM analysis provided a starting
point for the pursuit of an X-ray structure from the crys-
tals. In particular, the molecular dimensions and shape
obtained from the analysis aided our understanding of
the crystal packing and provided an initial molecular
envelope for phase extension via noncrystallographic
symmetry averaging (Chen et al., 2001). The structure of
the C-form crystals was finally determined to 3.3 Å res-
olution (Chen et al., 2001), employing single isomorphous
replacement diffraction data obtained from both the P-
and C-form crystals. Some disorder was observed in the
X-ray electron density maps, suggestive of partial pro-
teolytic degradation during the crystallization time
course. Retrospective N-terminal sequencing of the crys-
tallized material then indicated that a significant percent-
age of the material within the crystal was cleaved imme-
diately N-terminal to Ser 139. Cleavage at this site was
thus a possible cause of the disorder. While this un-
doubtedly complicated interpretation of the X-ray struc-
ture (Chen et al., 2001), our results provide the first
atomic level view of the ectodomain of a paramyxoviral
fusion protein.
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MATERIALS AND METHODS
Virus
A vaccine preparation of the V4 isolate (Queensland/66
strain) of NDV was obtained from Arthur Webster (Pty)
Ltd. (Northmead, New South Wales, Australia) and prop-
agated in 10-day-old embryonated chicken eggs. Virus
was harvested and purified from allantoic fluids as de-
scribed previously (Hodder et al., 1994, 1993). The puri-
fied virus was snap-frozen and stored at 70°C.
Cloning of the cDNA of NDV-F
The single-stranded viral RNA was isolated from puri-
fied virus using TRISOLVTM reagent (Biotecx Laborato-
ries). A Stratagene RT-PCR kit was used to generate
cDNA for cloning into the pCR-Script vector. The RT and
PCR primers were designed based on the mRNA se-
quence of the NDV strain, Que/66 (Toyoda et al., 1989).
The RT reaction was conducted with the primer (5-
ACGGGTAGAAGATTCTGGATCC-3), which is comple-
mentary to the 3 end of negative-stranded RNA encod-
ing F protein. The RT primer and the primer 5-ATATCGC-
CCTTTGGTCATCTAC-3, which is complementary to the
3-end of transcribed F-protein gene, were used in the
PCR to amplify the full-length cDNA of NDV-F. The PCR-
amplified cDNA was blunt-end ligated into the SrfI site of
the predigested pCR-Script cloning vector using pCR-
ScriptTM cloning kits (Stratagene). The ligation mixture
was then transformed into NM522 competent cell (Strat-
agene) and positive clones were identified by PCR
screening of single white colonies. Plasmid DNA was
purified from colony 7 (designated as pCR-Script-F) using
Qiagen-tip 100 (Qiagen) and sequenced on an automatic
DNA sequencer using ABI PRISMTM dye terminator cycle
sequencing ready-reaction kit (Perkin–Elmer). In addition
to the two universal primers (T3 and T7) that were used
for sequencing the NDV-F cDNA from the 3 end and the
5 end, the following three primers were also designed
for sequencing: 5-CCATTATCGGTGGTGTAGCTC-3
(PFN-2), 5-GTGACATTCCCTATGTCTCC-3 (PFN-3) and 5-
CACAGCTTCTCCATAATTTTG-3 (PFC-2). The NDV-F cDNA
was cloned into the vector in a reverse orientation.
Construction of mammalian cell expression vector
The following steps were performed to construct a mam-
malian cell expression vector producing the ectodomain of
NDV-F with a c-myc epitope tag (Hoogenboom et al., 1991)
at the C-terminus. (i) The pCR-Script-F was digested with
SphI and EcoRI to produce a fragment, FEcoRI-SphI, which
contained the transcriptional start signal, the noncoding
region, and the regions encoding the signal peptide, entire
ectodomain, and partial transmembrane domain of NDV-F.
This fragment was then cloned into the M13 vector di-
gested with SphI and EcoRI to give a clone designated as
M13-FEcoRI-SphI. (ii) To remove the transmembrane coding
region, a fragment from 72 base-pairs upstream of the
EcoRV site to the end of ectodomain, designated F-EcoRV-TM,
was amplified by PCR to give a product with EcoRV site on
the 5 end of the sense strand and an XbaI site on the 3
end of the sense strand. The primers used for the PCRwere
5-GGGGAATTTGATGCAACTTATC-3 and 5-CGATATAG-
GTAATTCTAGAGGATGTGCTGGTC-3. This fragment was
then digested with XbaI and ligated with the c-myc frag-
ment containing a complementary overhanging XbaI site
to give F-EcoRV-TMc-myc. The c-myc fragment contains a
sequence encoding the c-myc tag residues EQKLI-
SEEDLN (Hoogenboom et al., 1991) followed by a stop
codon and EcoRI site plus overhanging XbaI site on the
5 end of the sense strand and HindIII site on the 3 end
of the sense strand. The fragment was generated by
annealing two synthetic oligonucleotides: 5-CTAGAGA-
ACAAAAACTCATCTCAGAAGAGGATCTGAATTAGGAATT-
CA-3 and 5-AGCTTGAATTCCTAATTCAGATCCTCTTCT-
GAGATGAGTTTTTGTTCT-3. (iii) F-EcoRV-TMc-myc was cloned
into a pTZ18U vector digested with SmaI and HindIII to
give pTZ-F-EcoRV-TMc-myc from which the desired fragment
containing the partial F-protein gene and c-myc coding
region was recovered by digesting the plasmid with
EcoRV and HindIII. (iv) The recovered fragment was then
ligated into plasmid M13-FEcoRI–SphI digested with EcoRV
and HindIII to give M13-Fectodomain-c-myc, from which fragment
Fectodomain-c-myc was recovered by digesting the plasmid with
EcoRI. The fragment Fectodomain-c-myc contained the transcrip-
tional start signal, noncoding region, coding region for
the signal peptide and entire ectodomain of NDV-F,
c-myc tag, and stop codon. (v) Finally, the fragment
Fectodomain-c-myc was ligated into the EcoRI site of the
pEE14 vector (Bebbington and Hentschel, 1987) to give
a mammalian cell expression vector for production of
the ectodomain of NDV-F with a c-myc tag on the
C-terminus, designated as pEE14-FNDV.
Expression of the ectodomain of NDV-F in
mammalian cells
To express the ectodomain of NDV-F in mammalian
cells, the plasmid pEE14-FNDV was transfected into Chi-
nese hamster ovary (CHO-K1) cells and its mutant cell
line Lec-3.2.8.1 (Stanley, 1989) using lipofectamine (Life
Technology). Transfected stable cells were selected by
growth in glutamine-free medium (Glasgow modification
of Eagle’s medium (GMEM), ICN Biomedicals, Australia)
supplemented with 25 M methionine sulfoximine (MSX,
Sigma) and 10% dialyzed fetal calf serum (FCS; Sigma).
After 11 days growth in the selection medium, the super-
natant was screened for the expression of F protein by
dot blot using the 9E10 monoclonal antibody raised
against the c-myc tag (Evan et al., 1985) as the first
antibody and sheep anti-mouse HRPO conjugate (Sile-
nus, Australia) as the secondary antibody. The blot was
developed using TMB as the substrate (McKimm-
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Breschkin, 1990). The cells secreting the highest levels
of F protein were subcloned by limiting dilution and were
amplified. To compare relative expression levels, the
cells were metabolically labeled with [35S]methionine.
After 24 h growth, the secreted products from the labeled
cells were immunoprecipitated with 9E10 and protein A
agarose beads. The precipitated product was then ana-
lyzed by SDS–PAGE and autoradiography. Authenticity of
the products secreted from the high expressing clones
was confirmed by Western blot analyses of the immuno-
precipitated products using both 9E10 and polyclonal
antibodies raised against NDV-F (Gorman et al., 1990,
1992) as the first antibody and a sheep anti-mouse-
HRPO or sheep anti-rabbit-HRPO (Silenus) as the sec-
ondary antibody. The best clone of each cell line was
used for the protein production.
Production of F protein in cell culture
For small-scale production of the recombinant F pro-
tein, a clone selected by limiting dilution was amplified to
confluence in the T180 flasks with GMEM supplemented
with 25 M MSX and 10% dialyzed FCS. Subsequently
the cells were maintained in GMEM supplemented with
25 M MSX and 5% normal FCS for the production of F
protein. The supernatants containing secreted F protein
were harvested every 3 days and the cells were refed.
For large-scale production, the cells were amplified to
about 80% confluence in T180 flasks with GMEM sup-
plemented with 25 M MSX and 10% dialyzed FCS.
These cells were then used to seed roller bottles and
subsequently spinner flasks in GMEM containing 25 M
MSX and 5% FCS. The supernatant containing secreted F
protein was harvested every day and the cells were refed
with fresh medium.
Protein isolation
For purification of secreted F protein, each lot of 10–15
l of harvested culture supernatant was centrifuged or
filtered, supplemented with 0.02% sodium azide, and
adjusted to pH 8.0 by adding 5 ml 3.0 M Tris–HCl buffer
per liter. The supernatant was then loaded onto two 9E10
affinity columns (50 and 30 ml connected sequentially)
equilibrated with Tris-buffered saline containing 0.02%
sodium azide (TBSA), pH 8.0, at 4°C at a flow rate of
1.0–1.5 ml/min. The 9E10 affinity columns were prepared
by coupling the protein A purified 9E10 to divinylsul-
phone-activated agarose beads (medium Mini-LeakTM,
Kem-En-Tec, Denmark) following the recommended pro-
cedure. The loaded columns were then thoroughly
washed with the TBSA and the bound protein eluted with
0.5–1.0 mg/ml c-myc peptide EQKLISEEDLN (Hoogen-
boom et al., 1991) in TBSA followed by sodium citrate, pH
3.0, buffer at room temperature (McKern et al., 1997).
Typically, 10 ml peptide solution was used for elution of
the 50-ml column and 5 ml peptide solution for the 30-ml
column. The peptide-eluted protein was concentrated in
an Amicon ultrafiltration cell equipped with a YM30
membrane and further purified on a Superose-6 FPLC
gel-filtration column (24 ml, Pharmacia Biotech) at room
temperature. The column was equilibrated and eluted
with 20 mM Tris–HCl, pH 7.5, buffer containing 100 mM
NaCl. Purity of the protein was examined by SDS–PAGE.
Identity of the protein was confirmed by N-terminal
amino acid sequence analysis. Matrix-assisted laser de-
sorption/ionization (MALDI) mass spectrometry (MS) of
the protein was performed using a Bruker Reflex time-
of-flight mass spectrometer according to previously de-
scribed procedures (Pitt et al., 2000) .
Trypsin treatment of recombinant F0
To investigate the cleavage of recombinant F0 into
disulfide-linked F2 and F1 polypeptides, F0 was incubated
with trypsin (TPCK-treated, Worthington) at a w/w ratio of
20:1 (F0:trypsin) in 20 mM Tris–HCl buffer (pH 7.5) con-
taining 5 mM CaCl2 at 37°C for 1 h or at room temper-
ature for several hours. Digestion mixtures were ana-
lyzed by SDS–PAGE on a 12% gel. The trypsin-treated
protein was also analyzed by gel-filtration chromatogra-
phy and compared to the untreated F0. To do this, 200–
400 g of each sample was loaded separately onto an
analytical Superose-6 FPLC gel-filtration column (24 ml,
Pharmacia Biotech) equilibrated and eluted with 20 mM
Tris–HCl buffer (pH 7.5) containing 100 mM NaCl at a
flow rate of 0.25 ml/min.
Electron microscopic analysis
For single particle imaging by transmission electron
microscopy of virus-derived NDV-F and recombinant F0,
samples were diluted in phosphate-buffered saline to
concentrations on the order of 0.01–0.03 mg/ml and
droplets of approximately 5 l applied to carbon-coated
400-mesh gold grids which had been glow discharged in
nitrogen. The protein was stained with 2% potassium
phosphotungstate at pH 6.0 (Probing and Structure), 2%
uranyl acetate (Agar), or 2% uranyl formate according to
previously described procedures (Russell and Hyder,
1996). Micrographs were recorded with either a JEOL
100B transmission electron microscope operating at 60
kV or with a JEOL 2000FX transmission electron micro-
scope operating at 120 kV, at nominal magnifications of
80,000 or 100,000. Magnification was calibrated by
comparison with the crystallographically determined di-
mensions of both tobacco mosaic virus (Mandelkow and
Holmes, 1974) and neuraminidase tetramers in complex
with NC10 Fab’s (Tulloch et al., 1986), imaged under
identical conditions to the above.
Image processing
Micrographs were digitized with a PDS 1010G micro-
densitometer (Perkin–Elmer) using a 20-m raster step.
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Subimages of individual particles were manually se-
lected for classification, alignment, and averaging, in-
cluding in the data set any particles which could be
windowed without inclusion of neighboring particles.
Data sets comprising the selected subimages were
aligned and classified using a multireference alignment
algorithm based on principal component analysis fol-
lowed by k-means classification (Harauz et al., 1988) as
implemented in the SPIDER image processing suite
(Frank et al., 1996). In each case the data set was
classified into 8 to 10 subclusters, each subcluster yield-
ing a corresponding averaged image. Averaged images
derived from very small subclusters were discarded from
further consideration. A cylindrically symmetric molecu-
lar envelope for use in phase extension (Chen et al.,
2001) was generated from a single selected averaged
image by first applying in-plane mirror averaging about
the central axis and then transforming this into a set of
coaxial disks with individual radii corresponding to that
of the half-width of the particle at the respective axial
point.
Crystallization of recombinant F0
All crystallization trials were performed using the
hanging-drop vapor diffusion method (McPherson, 1982)
at either 20 or 4°C. Initial trials were conducted using
Crystal Screens I and II (Hampton Research), followed by
screening and subsequent fine tuning of salt precipitant
conditions.
Preliminary X-ray diffraction analysis
Diffracting crystals were obtained from recombinant F0
produced in CHO-K1 cells using (NH4)2SO4 and Li2SO4
as precipitants. For X-ray diffraction analysis of the crys-
tals grown from the (NH4)2SO4 at room temperature, a
single crystal was transferred to a glass capillary in
38–50% saturated (NH4)2SO4 (pH 8.5) and mounted on an
X-ray goniometer. The same crystals were also exam-
ined under cryogenic conditions by slowly transferring a
single crystal through a series of solutions containing
100 mM Tris–HCl (pH 8.5), 48% saturated (NH4)2SO4, and
sucrose in 4% increments from 0 to 40%. To minimize the
rate of diffusion, the transfers were done with the solu-
tions sitting on ice. Crystals, in a final solution of 48%
saturated (NH4)2SO4, 40% sucrose, and 100 mM Tris–HCl
(pH 8.5), were flash-frozen in a rayon loop (Teng, 1990)
mounted on an X-ray goniometer in a stream of cryo-
cooled nitrogen gas at 108 K using an MSC low-temper-
ature system (Molecular Structure Corp.). The diffraction
data were collected using either an R-AXIS II or an
R-AXIS IV image-plate detector (Rigaku) equipped with a
helium window and mounted on a M18XHF-SRA rotating
anode generator (MacScience) operating at 40 kV/50 mA
with a copper anode and mirror focusing optics. All
frames were collected as 0.5° oscillations at a crystal-
to-detector distance of 240 mm with an exposure time of
1 h. X-ray analysis and data collection of crystals grown
from Li2SO4 followed the same procedure except that the
crystals were transferred through a series of solutions
containing 100 mM Tris–HCl (pH 8.5), 1.7 M Li2SO4, and
sucrose in 4% increments from 0 to 40% prior to mount-
ing, with the final cryoprotectant solution containing 100
mM Tris–HCl (pH 8.5), 1.5 M Li2SO4, and 40% sucrose.
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